Меню

+7 495 640-17-71
info@dna-technology.com

Search

Streptococcus agalactiae

The actual product may vary from the images shown on the website.

Group B Streptococcus (GBS) is a part of normal vaginal flora that can be found in 5-35 % of pregnant women. In obstetrics, GBS commonly is associated with infections of urinary tract, chorioamnionitis, puerperal endometritis, bacteriaemia at birth and in postpartum period, premature rupture of membranes and preterm birth. The risk of intranatal infection during vaginal delivery estimated at 50-60 %.

With reference to The American Society for Disease Control (Preventing Early-Onset Group B Strep Disease (GBS), 2016) the risk of infection for fill-term infant is 1-2 %, for preterm infant – 15-20 % and at gestational age less than 28 weeks – 100 %. Moreover, GBS is considered the main cause of newborn sepsis in USA.

GBS diagnostics (in accordance with «Prevention of Perinatal Group B Streptococcal Disease: Revised Guidelines from CDC», 2010):

• At 35-37 weeks gestational age routinely by cultural method with selective medium;

• In case of onset of labor in women with unknown GBS status, the molecular genetic methods are recommended for intranatal research.

The Streptococcus agalactiae Real-Time PCR Detection Kit is in vitro DNA test, which is intended for the specific identification of Streptococcus agalactiae in human biological samples.

Sample: swabs from vagina, rectum, nasal pharynx, urine, spinal fluid, blood, autopsy samples

DNA extraction: PREP-NA, PREP-GS, PREP-RAPID extraction kits

Certification: RUO

Типы детекции:
Real-time format is designed to detect PCR results during amplification with the help of detecting amplifiers (in real time).
RT

Storage requirements

+2...+8° С

Shelf life

12 months

Detection instruments

Number of tests

Tubes(ml)/ Strips

Product number

DT instruments (DNA-Technology); iQ5, iCycler (Bio-Rad) with 2 or more detection channels

48

0.2

R1-P012-23/4EU

0.2х8

R1-P012-S3/4EU